Mechanism of focal cerebral ischemic tolerance in rats with ischemic preconditioning involves MyD88- and TRIF-dependent pathways

Han,Li; Mingyue,Jin; Tao,Lv; Junhong,Guan

doi:10.3892/etm.2013.1318

Mechanism of focal cerebral ischemic tolerance in rats with ischemic preconditioning involves MyD88- and TRIF-dependent pathways

Authors:
- Li Han
- Jin Mingyue
- Lv Tao
- Guan Junhong
View Affiliations

Affiliations: Department of Neurosurgery, Shengjing Hospital, China Medical University, Shenyang, Liaoning 110004, P.R. China
Published online on: September 27, 2013 https://doi.org/10.3892/etm.2013.1318
Pages: 1375-1379

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to explore the involvement of Toll-like receptor 4 (TLR4) and the downstream myeloid differentiation factor 88 (MyD88)‑dependent and -independent pathways in the mechanisms of cerebral ischemic tolerance. Using an improved middle cerebral artery occlusion method, we constructed a preconditioned ischemic brain model in rats. Sham and ischemia‑reperfusion groups were also established. The expression levels of proteins in the MyD88/nuclear factor-κB (NF-κB) pathway (MyD88‑dependent) were compared with those in the Toll/interleukin-1 receptor‑domain‑containing adaptor‑inducing interferon-β (TRIF)/interferon regulatory factor‑3 (IRF-3) pathway (MyD88‑independent) by western blot analysis. NF-κB and IRF-3 protein expression levels within cells were determined by immunofluorescence staining of frozen tissue sections. Western blot analysis showed a downregulation of MyD88 protein expression in the brain tissue of ischemic preconditioned rats; however, NF-κB, TRIF and IRF-3 protein expression levels were upregulated. Immunofluorescence staining showed that NF-κB protein was mainly located in the cytoplasm in ischemic preconditioned rats and IRF-3 was predominantly located in the nucleus. The results indicate that changes in the two TLR4 downstream pathways are the main mechanisms involved in the development of brain ischemic tolerance with ischemic pretreatment.

View Figures

View References

1	Kuroda S and Siesjö BK: Reperfusion damage following focal ischemia: pathophysiology and therapeutic windows. Clin Neurosci. 4:199–212. 1997.PubMed/NCBI
2	Zhang X, Li H, Hu S, Zhang L, Liu C, Zhu C, Liu R and Li C: Brain edema after intracerebral hemorrhage in rats: the role of inflammation. Neurol India. 54:402–407. 2006. View Article : Google Scholar : PubMed/NCBI
3	Tang SC, Arumugam TV, Xu X, Cheng A, Mughal MR, Jo DG, Lathia JD, Siler DA, Chigurupati S, Ouyang X, et al: Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc Natl Acad Sci USA. 104:13798–13803. 2007. View Article : Google Scholar : PubMed/NCBI
4	Takeda K, Kaisho T and Akira S: Toll-like receptors. Annu Rev Immunol. 21:335–376. 2003. View Article : Google Scholar
5	Granowitz EV, Porat R, Mier JW, Orencole SF, Kaplanski G, Lynch EA, Ye K, Vannier E, Wolff SM and Dinarello CA: Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J Immunol. 151:1637–1645. 1993.
6	Erroi A, Fantuzzi G, Mengozzi M, Sironi M, Orencole SF, Clark BD, Dinarello CA, Isetta A, Gnocchi P, Giovarelli M, et al: Differential regulation of cytokine production in lipopolysaccharide tolerance in mice. Infect Immun. 61:4356–4359. 1993.PubMed/NCBI
7	Marsh B, Stevens SL, Packard AE, Gopalan B, Hunter B, Leung PY, Harrington CA and Stenzel-Poore MP: Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for IRF3. J Neurosci. 29:9839–9849. 2009. View Article : Google Scholar : PubMed/NCBI
8	Tasaki K, Ruetzler CA, Ohtsuki T, Martin D, Nawashiro H and Hallenbeck JM: Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res. 748:267–270. 1997. View Article : Google Scholar : PubMed/NCBI
9	Rosenzweig HL, Lessov NS, Henshall DC, Minami M, Simon RP and Stenzel-Poore MP: Endotoxin preconditioning prevents cellular inflammatory response during ischemic neuroprotection in mice. Stroke. 35:2576–2581. 2004. View Article : Google Scholar : PubMed/NCBI
10	Stenzel-Poore MP, Stevens SL, Xiong Z, Lessov NS, Harrington CA, Mori M, Meller R, Rosenzweig HL, Tobar E, Shaw TE, et al: Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet. 362:1028–1037. 2003. View Article : Google Scholar
11	Pradillo JM, Fernández-López D, García-Yébenes I, Sobrado M, Hurtado O, Moro MA and Lizasoain I: Toll-like receptor 4 is involved in neuroprotection afforded by ischemic preconditioning. J Neurochem. 109:287–294. 2009. View Article : Google Scholar : PubMed/NCBI
12	Häcker H, Redecke V, Blagoev B, Kratchmarova I, Hsu LC, Wang GG, Kamps MP, Raz E, Wagner H, Häcker G, et al: Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature. 439:204–207. 2006.PubMed/NCBI
13	Rolls A, Shechter R, London A, Ziv Y, Ronen A, Levy R and Schwartz M: Toll-like receptors modulate adult hippocampal neurogenesis. Nat Cell Biol. 9:1081–1088. 2007. View Article : Google Scholar : PubMed/NCBI
14	Ekdahl CT, Kokaia Z and Lindvall O: Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience. 158:1021–1029. 2009. View Article : Google Scholar : PubMed/NCBI
15	Rosenzweig HL, Minami M, Lessov NS, Coste SC, Stevens SL, Henshall DC, Meller R, Simon RP and Stenzel-Poore MP: Endotoxin preconditioning protects against the cytotoxic effects of TNFalpha after stroke: a novel role for TNFalpha in LPS-ischemic tolerance. J Cereb Blood Flow Metab. 27:1663–1674. 2007. View Article : Google Scholar : PubMed/NCBI
16	Stevens SL, Leung PY, Vartanian KB, Gopalan B, Yang T, Simon RP and Stenzel-Poore MP: Multiple preconditioning paradigms converge on interferon regulatory factor-dependent signaling to promote tolerance to ischemic brain injury. J Neurosci. 31:8456–8463. 2011. View Article : Google Scholar
17	Vartanian KB, Stevens SL, Marsh BJ, Williams-Karnesky R, Lessov NS and Stenzel-Poore MP: LPS preconditioning redirects TLR signaling following stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic injury. J Neuroinflammation. 8:1402011. View Article : Google Scholar : PubMed/NCBI
18	Guo B and Cheng G: Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK. J Biol Chem. 282:11817–11826. 2007. View Article : Google Scholar : PubMed/NCBI
19	Piccioli P, Porcile C, Stanzione S, Bisaglia M, Bajetto A, Bonavia R, Florio T and Schettini G: Inhibition of nuclear factor-kappaB activation induces apoptosis in cerebellar granule cells. J Neurosci Res. 66:1064–1073. 2001. View Article : Google Scholar : PubMed/NCBI